ClinicalTrials.Veeva

Menu
I

Instituto de Neumonologia y Dermatologia | Buenos Aires, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling
Prurigo Nodularis
Drug: Povorcitinib
Drug: Placebo

Trial sponsors

Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems